| CDC’s PrEP Clinical Practice Guideline and Strategies for Ending the HIV Epidemic in the U.S. |
Webpage (HTML) |
The Centers for Disease Control and Prevention |
| Clinical Guidelines Portal |
Webpage (HTML) |
Clinicalinfo.HIV.gov |
| Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment, and Care for Key Populations |
Webpage (HTML) |
World Health Organization |
| Consolidated guidelines on differentiated HIV testing services |
Webpage (HTML) |
World Health Organization |
| Guidelines & Recommendations |
Webpage (HTML) |
TalkPrEP |
| Guidelines and Recommendations |
Webpage (HTML) |
The Centers for Disease Control and Prevention |
| Guidelines for HIV post-exposure prophylaxis |
Webpage (HTML) |
World Health Organization |
| Guidelines for the Prevention and Treatment of Opportunistic Infections in Children With and Exposed to HIV |
Webpage (HTML) |
Clinicalinfo.HIV.gov |
| Guidelines on long-acting injectable cabotegravir for HIV prevention |
Webpage (HTML) |
World Health Organization |
| HIV Infection: Detection, Counseling, and Referral |
Webpage (HTML) |
Centers for Disease Control and Prevention |
| HIV Infection: Screening |
Webpage (HTML) |
U.S. Preventive Services Task Force |
| Medical Practice Guidelines and HIV/AIDS Literature Search |
Webpage (HTML) |
U.S. National Library of Medicine |
| National Consolidated Guidelines |
PDF |
Southern African HIV Clinicians Society |
| Preexposure Prophylaxis for HIV Updated Recommendations From the 2024 International Antiviral Society–USA Panel |
Webpage (HTML) |
JAMA Network |
| WHO guidelines on the management of advanced HIV disease |
Webpage (HTML) |
World Health Organization |
